Premium Grade | UK Supply | Research Peptide | COA Certified | >99% Purity | Worldwide Delivery

(Tripeptide, 3 amino acids)

Brief Summary

Crystagen is a synthetic short-chain peptide studied in laboratory settings for its relationship with thymic biology, immune-cell regulation and gene-expression pathways. Also identified by the sequence EDP, Crystagen contains three amino acids: glutamic acid, aspartic acid and proline. The peptide belongs to the Khavinson-class group of short peptide bioregulators investigated for tissue-associated molecular activity. Research has focused particularly on thymic epithelial cells, lymphocyte proliferation, cytokine-associated signalling and cellular ageing processes. Crystagen has also been examined in experimental models involving chromatin organisation, immune-cell communication and stress-response gene expression. Within scientific research catalogues, Crystagen is valued for in vitro and preclinical investigation involving thymic tissue biology, T-lymphocyte markers, cellular proliferation and short-peptide bioregulation. Its defined three-amino-acid sequence supports structured laboratory study, analytical characterisation and reproducible peptide research within professional scientific environments.

Product Overview

Crystagen is a laboratory-grade synthetic tripeptide developed for controlled research into thymic tissue biology, immune-cell signalling and short-peptide regulation. Its amino-acid sequence, Glu–Asp–Pro, is commonly abbreviated as EDP and contains two acidic residues followed by a structurally rigid proline residue. This compact molecular arrangement allows researchers to investigate how short peptide sequences may interact with cellular components and influence immune-associated gene-expression pathways. Crystagen has been examined in thymic epithelial cell and lymphocyte models, with particular attention given to cellular proliferation, immune-cell differentiation, cytokine expression and age-associated cellular changes. The peptide is also relevant to comparative studies involving Thymalin, Thymogen and other Khavinson-class bioregulators. Its defined composition, low molecular weight and reproducible molecular characteristics support controlled investigation into peptide bioregulation, thymic cell signalling, immune-associated molecular responses and cellular stress pathways.

Scientific Background

From a molecular science perspective, Crystagen is studied as a short peptide bioregulator associated with thymic tissue and immune-cell research. Experimental studies have examined its relationship with lymphocyte proliferation, thymic epithelial cell activity and immune-associated cellular markers under controlled laboratory conditions. Research has also investigated cytokine-related pathways, including molecular signals involved in cellular communication and regulated immune responses. Additional attention has been given to heat-shock protein expression, chromatin organisation and cellular adaptation to experimental stress conditions. Broader short-peptide research proposes that tripeptides may interact with selected DNA regions or chromatin-associated components and contribute to the regulation of tissue-specific genes, although these proposed mechanisms require further independent investigation. Crystagen therefore provides a compact molecular tool for examining thymic biology, immune-cell signalling, cellular ageing processes and the relationship between defined amino-acid sequences and gene-expression regulation.

Research Applications

Crystagen is applied in laboratory research across peptide science, thymic biology, molecular immunology and cellular bioregulation. Researchers use the peptide to examine thymic epithelial cell responses, lymphocyte proliferation, T-cell-associated markers, cytokine expression and cellular ageing pathways under controlled experimental conditions. Additional research applications include analysis of cellular differentiation, chromatin organisation, heat-shock protein expression, apoptosis-associated signalling and experimentally induced stress responses. Crystagen may also be used to investigate proposed peptide-DNA interactions, tissue-associated gene regulation and the influence of defined amino-acid sequences on immune-cell communication. Its three-residue structure supports research into peptide simplification, sequence-specific signalling, molecular recognition and structure-activity relationships. These applications contribute to a broader understanding of short-peptide biology and how compact synthetic sequences may be examined in relation to thymic and immune-associated cellular regulation. Crystagen is supplied as a research compound for analytical, in vitro and controlled preclinical investigation only.

Technical Specifications

Contents: 20mg Crystagen
Form: Lyophilised powder
Purity: >99% (HPLC Verified)
Molecular Formula: C₁₄H₂₁N₃O₈
Molecular Weight: 359.33 g/mol
Sequence: Glutamic Acid–Aspartic Acid–Proline
Peptide Length: 3 amino acids
pH Range: 6.7-7.3
Storage: Store between 2°C and 8°C 

Note: Reconstitute with Bacteriostatic Water

Explore Related Research Compounds
Continue exploring related laboratory research products from BioPlex Peptides.

View GHK-CU 50mg Research Compound ⟶
View NAD+500IU Research Compound ⟶
View Adipotide Research Compound ⟶

Research Preparation and Storage
Access BioPlex solutions, calculation tools and storage guidance for accurate and consistent laboratory preparation.

View Reconstitution Solutions ⟶
Use the Peptide Reconstitution Calculator ⟶
Read the Peptide Types and Storage Guide ⟶

Explore Related Research Articles
Continue your research with detailed BioPlex articles covering compound structures, scientific mechanisms and laboratory research pathways.

Disclaimer

For research purposes only. Not for human consumption